Stockreport

Nurix Therapeutics Announces Proposed Public Offering

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modul [Read more]